FDA Enforcement Class II Terminated

Amicus MNC Apheresis Kit - Double Needle - Product Usage: intended for use in the collection of blood components and mononuclear cells.

Recall: Z-1343-2021 · Reported April 14, 2021

Enforcement

Recall Number
Z-1343-2021
Event ID
87407
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Fenwal Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
April 14, 2021
Initiation Date
February 25, 2021
Classification Date
April 2, 2021
Termination Date
April 18, 2023
Address
3 Corporate Dr Ste 300, N/A, Lake Zurich, IL, 60047-8930, United States

Description

Amicus MNC Apheresis Kit - Double Needle - Product Usage: intended for use in the collection of blood components and mononuclear cells.

Reason

Some lots of Amicus MNC Apheresis and Amicus Exchange kits have leaking centrifuge packs during a procedure on the Amicus Separator using therapeutic protocols only. The defect is a blood leak at the boot, elbow, or in the channel on the separation chamber of the centrifuge pack.

Code Info

Product Code X6R2326; UDI: 04086000100144; Batch Numbers FA20E25234 ((Exp. 05/31/2022), FA20F23120 (Exp. 06/30/2022), FA20I21268 (Exp. 09/30/2022), and FA20J19246 (Exp. 10/31/2022).

Distribution

US Nationwide distribution in the states of GA, TX, TN, MD, CA, KS, MN, MA, NM, NC, LA, CO, KY, NV, PA, UT, MI, NJ, IL, MD, OH, NY, FL.

Quantity

4488 units